Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK “Inhibitors”

REFERENCES

• Alt, J. R., A. B. Gladden, and J. A. Diehl. 2002. p21(Cip1) promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:8517–8523.
   PubMed Web of Science ®Google Scholar
• Aprelikova, O., Y. Xiong, and E. T. Liu. 1995. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270:18195–18197.
   PubMed Web of Science ®Google Scholar
• Bagui, T. K., R. J. Jackson, D. Agrawal, and W. J. Pledger. 2000. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol. Cell. Biol. 20:8748–8757.
   PubMedGoogle Scholar
• Bagui, T. K., S. Mohapatra, E. Haura, and W. J. Pledger. 2003. p27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol. Cell. Biol. 23:7285–7290.
   PubMedGoogle Scholar
• Baptist, M., F. Lamy, J. Gannon, T. Hunt, J. E. Dumont, and P. P. Roger. 1996. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles. J. Cell. Physiol. 166:256–273.
   PubMedGoogle Scholar
• Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:805–814.
   PubMed Web of Science ®Google Scholar
• Blain, S. W., E. Montalvo, and J. Massague. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272:25863–25872.
   PubMed Web of Science ®Google Scholar
• Boehm, M., T. Yoshimoto, M. F. Crook, S. Nallamshetty, A. True, G. J. Nabel, and E. G. Nabel. 2002. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21:3390–3401.
   PubMed Web of Science ®Google Scholar
• Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583.
   PubMed Web of Science ®Google Scholar
• Chiariello, M., E. Gomez, and J. S. Gutkind. 2000. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem. J. 349:869–876.
   PubMedGoogle Scholar
• Coulonval, K., L. Bockstaele, S. Paternot, J. E. Dumont, and P. P. Roger. 2003. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp. Cell Res. 291:135–149.
   PubMed Web of Science ®Google Scholar
• Coulonval, K., L. Bockstaele, S. Paternot, and P. P. Roger. 2003. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. J. Biol. Chem. 278:52052–52060.
   PubMed Web of Science ®Google Scholar
• Darbon, J. M., A. Devault, S. Taviaux, D. Fesquet, A. M. Martinez, S. Galas, J. C. Cavadore, M. Doree, and J. M. Blanchard. 1994. Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. Oncogene 9:3127–3138.
   PubMedGoogle Scholar
• Delmas, C., N. Aragou, S. Poussard, P. Cottin, J. M. Darbon, and S. Manenti. 2003. MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J. Biol. Chem. 278:12443–12451.
   PubMed Web of Science ®Google Scholar
• Depoortere, F., J. E. Dumont, and P. P. Roger. 1996. Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J. Cell Sci. 109:1759–1764.
   PubMedGoogle Scholar
• Depoortere, F., I. Pirson, J. Bartek, J. E. Dumont, and P. P. Roger. 2000. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol. Biol. Cell 11:1061–1076.
   PubMed Web of Science ®Google Scholar
• Depoortere, F., A. Van Keymeulen, J. Lukas, S. Costagliola, J. Bartkova, J. E. Dumont, J. Bartek, P. P. Roger, and S. Dremier. 1998. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140:1427–1439.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., and C. J. Sherr. 1997. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17:7362–7374.
   PubMed Web of Science ®Google Scholar
• Dietrich, C., K. Wallenfang, F. Oesch, and R. Wieser. 1997. Translocation of cdk2 to the nucleus during G1-phase in PDGF-stimulated human fibroblasts. Exp. Cell Res. 232:72–78.
   PubMedGoogle Scholar
• Dong, F., D. Agrawal, T. Bagui, and W. J. Pledger. 1998. Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. Mol. Biol. Cell 9:2081–2092.
   PubMedGoogle Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Farkas, T., K. Hansen, K. Holm, J. Lukas, and J. Bartek. 2002. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J. Biol. Chem. 277:26741–26752.
   PubMedGoogle Scholar
• Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713–724.
   PubMed Web of Science ®Google Scholar
• Gao, H., X. Ouyang, W. Banach-Petrosky, A. D. Borowsky, Y. Lin, M. Kim, H. Lee, W. J. Shih, R. D. Cardiff, M. M. Shen, and C. Abate-Shen. 2004. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc. Natl. Acad. Sci. USA 101:17204–17209.
   PubMed Web of Science ®Google Scholar
• Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581–1588.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and S. J. Elledge. 1998. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev. 12:285–289.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, and E. Swindell. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387–400.
   PubMed Web of Science ®Google Scholar
• Hengst, L., U. Gopfert, H. A. Lashuel, and S. I. Reed. 1998. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev. 12:3882–3888.
   PubMedGoogle Scholar
• Iavarone, A., and J. Massague. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387:417–422.
   PubMedGoogle Scholar
• Ishida, N., T. Hara, T. Kamura, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355–14358.
   PubMed Web of Science ®Google Scholar
• Ishida, N., M. Kitagawa, S. Hatakeyama, and K. Nakayama. 2000. Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J. Biol. Chem. 275:25146–25154.
   PubMed Web of Science ®Google Scholar
• Jinno, S., S. C. Hung, and H. Okayama. 1999. Cell cycle start from quiescence controlled by tyrosine phosphorylation of cdk4. Oncogene 18:565–571.
   PubMedGoogle Scholar
• Kaldis, P. 1999. The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol. Life Sci. 55:284–296.
   PubMed Web of Science ®Google Scholar
• Kaldis, P., Z. W. Pitluk, I. A. Bany, D. A. Enke, M. Wagner, E. Winter, and M. J. Solomon. 1998. Localization and regulation of the cdk-activating kinase (Cak1p) from budding yeast. J. Cell Sci. 111:3585–3596.
   PubMedGoogle Scholar
• Kaldis, P., A. A. Russo, H. S. Chou, N. P. Pavletich, and M. J. Solomon. 1998. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol. Biol. Cell 9:2545–2560.
   PubMed Web of Science ®Google Scholar
• Kaldis, P., and M. J. Solomon. 2000. Analysis of CAK activities from human cells. Eur. J. Biochem. 267:4213–4221.
   PubMedGoogle Scholar
• Kato, A., H. Takahashi, Y. Takahashi, and H. Matsushime. 1997. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem. 272:8065–8070.
   PubMedGoogle Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487–496.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713–2721.
   PubMed Web of Science ®Google Scholar
• Kivinen, L., and M. Laiho. 1999. Ras- and mitogen-activated protein kinase kinase-dependent and -independent pathways in p21Cip1/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-beta1. Cell Growth Differ. 10:621–628.
   PubMedGoogle Scholar
• Kozar, K., M. A. Ciemerych, V. I. Rebel, H. Shigematsu, A. Zagozdzon, E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, R. T. Bronson, K. Akashi, and P. Sicinski. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477–491.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862.
   PubMed Web of Science ®Google Scholar
• Lacy, E. R., I. Filippov, W. S. Lewis, S. Otieno, L. Xiao, S. Weiss, L. Hengst, and R. W. Kriwacki. 2004. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 11:358–364.
   PubMed Web of Science ®Google Scholar
• Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18:6605–6615.
   PubMed Web of Science ®Google Scholar
• Larochelle, S., and R. P. Fisher. 2005. CDK-activating kinases: detection and activity measurements. Methods Mol. Biol. 296:279–290.
   PubMedGoogle Scholar
• Larochelle, S., J. Pandur, R. P. Fisher, H. K. Salz, and B. Suter. 1998. Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev. 12:370–381.
   PubMed Web of Science ®Google Scholar
• Leng, X., M. Noble, P. D. Adams, J. Qin, and J. W. Harper. 2002. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol. Cell. Biol. 22:2242–2254.
   PubMed Web of Science ®Google Scholar
• Lents, N. H., S. M. Keenan, C. Bellone, and J. J. Baldassare. 2002. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J. Biol. Chem. 277:47469–47475.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261–2268.
   PubMed Web of Science ®Google Scholar
• Liu, Y., C. Wu, and K. Galaktionov. 2004. p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells. J. Biol. Chem. 279:4507–4514.
   PubMedGoogle Scholar
• Matsuoka, M., J. Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265–7275.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Matsuura, I., N. G. Denissova, G. Wang, D. He, J. Long, and F. Liu. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226–231.
   PubMed Web of Science ®Google Scholar
• Miliani de Marval, P. L., E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D. G. Johnson, C. J. Conti, and M. L. Rodriguez-Puebla. 2004. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol. Cell. Biol. 24:7538–7547.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., A. E. Lenferink, B. Law, E. Hamilton, D. M. Brantley, L. R. Roebuck, and C. L. Arteaga. 2002. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploin-sufficient mammary epithelial cells but impaired in p27-null cells. Mol. Cell. Biol. 22:2204–2219.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., A. E. Lenferink, J. Simpson, D. M. Brantley, L. R. Roebuck, F. M. Yakes, and C. L. Arteaga. 2001. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J. Cell Biol. 153:917–932.
   PubMed Web of Science ®Google Scholar
• Nagahara, H., S. A. Ezhevsky, A. M. Vocero-Akbani, P. Kaldis, M. J. Solomon, and S. F. Dowdy. 1999. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc. Natl. Acad. Sci. USA 96:14961–14966.
   PubMed Web of Science ®Google Scholar
• Obaya, A. J., I. Kotenko, M. D. Cole, and J. M. Sedivy. 2002. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. J. Biol. Chem. 277:31263–31269.
   PubMed Web of Science ®Google Scholar
• Ortega, S., M. Malumbres, and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602:73–87.
   PubMed Web of Science ®Google Scholar
• Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and G. Draetta. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121:101–111.
   PubMed Web of Science ®Google Scholar
• Paternot, S., T. Arsenijevic, K. Coulonval, L. Bockstaele, J. E. Dumont, and P. P. Roger. 2006. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells. Cell Cycle 5:61–70.
   PubMed Web of Science ®Google Scholar
• Paternot, S., K. Coulonval, J. E. Dumont, and P. P. Roger. 2003. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J. Biol. Chem. 278:26533–26540.
   PubMed Web of Science ®Google Scholar
• Pavletich, N. P. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287:821–828.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Ren, S., and B. J. Rollins. 2004. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 117:239–251.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., and J. Massague. 1997. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492–503.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Rodier, G., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G. F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20:6672–6682.
   PubMed Web of Science ®Google Scholar
• Roger, P. P., P. Servais, and J. E. Dumont. 1987. Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. J. Cell Physiol. 130:58–67.
   PubMedGoogle Scholar
• Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massague, and N. P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325–331.
   PubMed Web of Science ®Google Scholar
• Sexl, V., J. A. Diehl, C. J. Sherr, R. Ashmun, D. Beach, and M. F. Roussel. 1999. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene 18:573–582.
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464–1478.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187–190.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and F. McCormick. 2002. The RB and p53 pathways in cancer. Cancer Cells 2:103–112.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18:2699–2711.
   PubMed Web of Science ®Google Scholar
• Shimotohno, A., C. Umeda-Hara, K. Bisova, H. Uchimiya, and M. Umeda. 2004. The plant-specific kinase CDKF;1 is involved in activating phosphorylation of cyclin-dependent kinase-activating kinases in Arabidopsis. Plant Cell 16:2954–2966.
   PubMed Web of Science ®Google Scholar
• Shin, I., J. Rotty, F. Y. Wu, and C. L. Arteaga. 2005. Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J. Biol. Chem. 280:6055–6063.
   PubMed Web of Science ®Google Scholar
• Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135–146.
   PubMedGoogle Scholar
• Sotillo, R., P. Dubus, J. Martin, E. de la Cueva, S. Ortega, M. Malumbres, and M. Barbacid. 2001. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:6637–6647.
   PubMed Web of Science ®Google Scholar
• Sugimoto, M., N. Martin, D. P. Wilks, K. Tamai, T. J. Huot, C. Pantoja, K. Okumura, M. Serrano, and E. Hara. 2002. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene 21:8067–8074.
   PubMedGoogle Scholar
• Tassan, J. P., S. J. Schultz, J. Bartek, and E. A. Nigg. 1994. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127:467–478.
   PubMed Web of Science ®Google Scholar
• Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama. 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376:358–362.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and F. McCormick. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cells 3:233–245.
   PubMed Web of Science ®Google Scholar
• Ukomadu, C., and A. Dutta. 2003. Inhibition of cdk2 activating phosphorylation by mevastatin. J. Biol. Chem. 278:4840–4846.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334–5344.
   PubMed Web of Science ®Google Scholar
• Watanabe, N., M. Broome, and T. Hunter. 1995. Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J. 14:1878–1891.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Weiss, R. H., A. Joo, and C. Randour. 2000. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 275:10285–10290.
   PubMed Web of Science ®Google Scholar
• Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750–1758.
   PubMed Web of Science ®Google Scholar